Preclinical Immunology & Vaccine Research
For immunology and vaccine programs requiring controlled in vivo studies, the contract vivarium model provides a stable research environment with integrated operational support.
Choose a LocationEnabling Breakthroughs in Immunology and Vaccine Research
Built for the practical demands of immunology and vaccine R&D, Mispro provides controlled, compliant contract vivarium environments with integrated husbandry, veterinary care, and regulatory oversight services. Scientists maintain direct control of study design and execution while generating reproducible in vivo data that informs early development decisions in immune biology, inflammation, and vaccine development.
Across our network of AAALAC-accredited contract vivarium facilities, biotech teams can conduct non-GLP rodent studies supporting immune response characterization, disease modeling, and evaluation of therapeutic and vaccine candidates.
Contract Vivarium Lab Space for Immunology and Vaccine Research
Biopharma teams advancing immunotherapies, vaccines, and treatments for inflammatory diseases benefit from controlled in vivo research environments that support complex immune biology studies. Mispro’s contract vivarium model provides research-ready vivarium space with integrated animal care and regulatory support, allowing scientists to maintain direct oversight of immunology studies within a professionally managed setting.
Secure Environments for In Vivo Immunology & Vaccine Studies
Mispro's contract vivarium facilities provide a turnkey option for preclinical R&D that keeps studies in-house and in the hands of founding scientists.
Whether your company is pioneering a new drug, is on the forefront of immunology, or has a team of scientists pursuing platform targets, Mispro is an optimal environment for your in vivo drug development research.
Immunology and Vaccine Research Areas Supported
Mispro’s contract vivarium environments support preclinical in vivo research across a wide range of immunology and vaccine development programs, including:
Innovation Across Our Network
- 88% Novel / Proprietary Research
- 58% Translational Programs
- 46% Platform Companies
Mispro vs. CRO
- 6X Increase in study throughput
- 50% Less spend over time
- 70% Reduction in failure rates
The Controlled Environments Your Immunology Program Demands
Built for the full range of immunology and vaccine research, from challenge models to efficacy work.